The G1-S transition in mammalian cells has been demonstrated to require the cyclin-dependent kinases cdk2, cdk3 and cdk4/6. Here we show that a novel kinase activity associated with cdk3¯uctuates throughout the cell cycle dierently from the expression of cyclin D1-, E-and A-associated kinase activities. Cdk3 kinase activity is neither aected by p16 (in contrast to cdk4/6) nor by E2F-1 (in contrast to cdk2), but is downregulated upon transient p27 expression. We found cdk3 to bind to p21 and p27. We provide evidence that p27 could be involved in the regulation of the cell cycle¯uctuation of cdk3 activity: cdk3 protein does not¯uctuate and interaction of cdk3 with p27, but not with p21, is lost when cdk3 kinase becomes active during the cell cycle. In Myc-overexpressing cells, but not in normal Rat1 cells, constitutive ectopic expression of cdk3 induces speci®c upregulation of cdk3-associated kinase activity that is still cell cycle phase dependent. Ectopic cdk3, but not cdk2, enhances Myc-induced proliferation and anchorage-independent growth associated with Myc activation, without eects on cyclin D1, E and A protein expression or kinase activities. High levels of cdk3 in Mycoverexpressing cells trigger up-and deregulation of E2F-dependent transcription without inducing the E2F-DNA binding capacity. In contrast to all other studied positive G1 regulators, cdk3 is unable to cooperate with ras in ®broblast transformation suggesting a function of cdk3 in G1 progression that is dierent from cyclin Dor E-associated kinase activities. Our data provide ®rst insights into the regulation of cdk3-associated kinase activity and suggest a model how cdk3 participates in the regulation of the G1-S transition.
Introduction
In the mammalian cell cycle, the transition from the Go/G1 phase to S phase, in which DNA replication occurs, has been shown to be regulated by cyclindependent kinases (cdks). Activities of cdks are controlled by association with cyclins and reversible phosphorylation reactions. An additional level of regulation is provided by inhibitors of cdks. Two families of these inhibitors have been described, those that interact with a wide range of cyclin/cdk complexes, including p21, p27 and p57, and those that only inhibit cdk4 and cdk6, including p15, p16, p18 and p19 (for reviews see Weinberg, 1995; Sherr and Roberts, 1995; Beijersbergen and Bernards, 1996) . G1/S and S phase substrates of these enzymes include proteins implicated in replication and transcription (Nigg, 1995; Pines, 1995) . Much evidence has accumulated to indicate that a critical substrate through which cdks control progression through G1 is the retinoblastoma protein (pRb). During early G1, cyclin D-cdk4/6 complexes operate to phosphorylate pRb and thereby activate the transcription factor E2F (Draetta, 1994) . In its simplest transcriptionally active form, E2F is a heterodimeric protein composed of an E2F and a DP family member, promoting the expression of DNA synthesis-and G1/S-regulatorygenes (Nevins, 1992; LaThangue, 1994) . Currently, ®ve distinct E2F family members and three DP proteins are known; E2F-1-3 have been shown to be controlled via pRb, whereas E2F-4 and E2F-5 associate with p107 and p130 rather than pRb. Among the genes activated via E2F are those for cyclin E and A, which when complexes with cdk2 promote the G1/S transition by further phosphorylation of pRb (Weinberg, 1995; Sherr and Roberts, 1995; Beijersbergen and Bernards, 1996; Zwicker and MuÈ ller, 1997) .
Beside cdk4/6 and cdk2 another cyclin-dependent kinase, cdk3, has been demonstrated to execute an essential function regulating S phase entry (van den Heuvel and Harlow, 1993; Hofmann and Livingston, 1996) . Cdk3 has originally been classi®ed as a cyclindependent kinase, because of its high sequence identity with both cdc2 and cdk2 and the ability to complement cdc28 mutations in yeast (Meyerson et al., 1992) . Transfection of a dominant-negative mutant of cdk3 causes a G1 block. This mutant phenotype was speci®cally rescued by wild-type cdk3 but not by cdk2. These data lead to the conclusion that cdk3 executes an essential function at the G1/S transition in the mammalian cell cycle, which is distinct from the function of cdk2 (van den Heuvel and Harlow, 1993) . It has further been shown that the G1 arrest induced by expression of a dominant-negative mutant of cdk3 is resistant to the action of SV40 T antigen, which is known to bind and inactivate unphosphorylated pRb. Dominant-negative cdk3 inhibited E2F-1-3 but not E2F-4 transcription activity in a pRb-independent manner. Cdk3 can bind to E2F/DP complexes in vivo, most likely through the DP partner (Hofman and Livingston, 1996) . In vitro experiments using recombi-nant puri®ed proteins demonstrated that cdk3 in complexes with A-and E-type cyclins phosphorylate pRb, an activity which is inhibited by high levels of p21 (Harper et al., 1995; Connell-Crowley et al., 1997) . Currently, however, neither the in vivo cyclin partner of cdk3 nor the in vivo substrates of this enzyme are known, which makes the in vivo regulation and function of cdk3 dicult to investigate.
We studied the regulation of a novel kinase activity associated with endogenous cdk3 and with ectopic cdk3 in Myc-overexpressing cells. We demonstrate that in both biological systems cdk3-associated kinase activity¯uctuates throughout the cell cycle, although cdk3 protein is constitutively expressed. Our data suggest that this regulation is not controlled by p16 or p21 and that this cdk3-associated kinase is not regulated by E2F-1. We provide evidence that interaction of p27 with cdk3 could be involved in the regulation of cdk3 kinase activity throughout the cell cycle. We further investigated the function of cdk3 by analysing the eects of ectopically expressed cdk3 in Myc-overexpressing cells. High levels of cdk3, but not cdk2, enhanced Myc-induced proliferation and anchorage-independent growth associated with activation of Myc, without any eect on cyclin D1, E and A protein expression or kinase activity. However, cdk3 in Mycoverexpressing cells induced up-and deregulation of E2F-dependent transcription. REF transformation assays revealed that cdk3 has no oncogenic activity and does not enhance c-Myc's transformation potential. The relevance of these data for the better understanding of regulation and function of cdk3 is discussed.
Results
Cdk3 binds to p21 and p27 and its associated kinase activity is not aected by p16 or E2F-1, but by p27
Immunoprecipitations were carried out using the anticdk3 antibody Y20 (St Cruz) and precipitates were subjected to kinase assays using histone H1 and GSTpRb as substrates. The levels of cdk3-associated kinase activities determined in extracts of dierent cell lines using the two dierent substrates were highly comparable ( Figure 1a ). Here it is important to note, that in the course of the described experiments we never detected any dierences between cdk3 kinase assays using pRb or histone H1 as substrate (see Figure 1 Ectopic overexpression of cdk2 or cdk3 protein in c-Myc overexpressing cells triggers speci®c induction of cdk2-and cdk3-associated kinase activities, respectively. (a) Cdk3-associated kinase activity against histone H1 (H1) and GST-pRb (pRb) was determined using the anti-cdk3 antibodies Y20 or Ab-1. (b). Stable cell lines were generated by transfecting Rat1-MycER cells with the empty CMV expression plasmid mediating G418 resistancy (control cell line), the CMV plasmid containing full length cdk2 or the CMV plasmid containing full length cdk3 cDNA. After 24 h activation of Myc by 4-hydroxytamoxifen (4-OHT) logarithmically growing cells were analysed for cdk2 and cdk3 protein expression and for kinase activities associated with cdk2 and cdk3 (the latter using the antibodies Y20 and Ab-1) against histone H1. To clearly visualize the dierences, the here presented exposures of the kinase assays are much shorter compared to those shown in (a). (c) Cdk3 protein is associated with p21 and p27 but not with cdk2. Shown are Western blots documenting the total amount of cdk2, cdk3 (analysed with the antibodies Y20 and Ab-1), p21 and p27 associated with cdk2 (M2) or cdk3 (Y20) in Rat1-MycER control cells and Rat1-MycER cells stably transfected with cdk3. In addition, immunoprecipitates performed with anti-p27 antibody were analysed for cdk3 protein below). The data on cdk3 expression and on kinase activity obtained with the Y20 antibody were reproduced using another anti-cdk3 antibody (Ab-1, Neomarkers) (Figure 1 and data not shown). To prove that these anti-cdk3 antibodies indeed immunoprecipitated a kinase activity associated with cdk3 we generated Rat1 and Rat1-MycER cell lines stably transfected with a G418-resistant CMV expression plasmid (to obtain control cells), the CMV plasmid containing full length human cdk2 cDNA, the CMV plasmid containing full length human cdk3 cDNA, or hemagglutinin (HA)-tagged cdk2 or cdk3. Overexpression of cdk3 or cdk3-HA in Rat1 cells did not lead to any induction of cdk3-associated kinase activity, neither in immunoprecipitates using the cdk3 antibodies nor in precipitates generated using an anti-HA antibody (data not shown). However, in Rat1-MycER cells after activation of Myc by treatment with 4-hydroxytamoxifen (4-OHT), ectopic expression of cdk3 or cdk3-HA was accompanied with a speci®c induction of kinase activity in Y20-, Ab-1-or in HAimmunoprecipitates, respectively ( Figure 1b and data not shown). These results show that both the Y20 antibody and the Ab-1 antibody speci®cally recognize cdk3 and not cdk2 and that a speci®c mechanism regulating cdk3 is induced in Myc-overexpressing cells (Figure 1b) . We next tested whether immunoprecipitates of cdk3 contained cdk2 protein, probably because of an interaction of these two proteins. Immunoprecipitations performed with extracts of Rat1-MycER control cells and Rat1-MycER/cdk3 cells revealed that cdk3 does not associate with cdk2. In contrast, cdk3 was seen to be associated with p21 and p27 ( Figure 1c ). Cdk3 protein was also detected in immunoprecipitates generated using anti-p27 antibody (Figure 1c) .
To investigate the role of the cyclin-dependent kinase inhibitors p16 or p27 in the regulation of cdk3-associated kinase activity, we transfected p16 negative cells with p16 and Rat1 cells with p27. Whereas we observed a clear downregulation of cdk4-associated kinase activity in p16 transfected cells, cdk3-associated kinase activity remained unaffected (Figure 2a) . We conclude that cdk3-associated kinase activity is not regulated via p16 and that the anti-cdk3-antibody Y20 immunoprecipitates a kinase distinct from cdk4/6. Overexpression of p27 triggered downregulation of cdk3-associated activity (Figure 2b ). The eects of high ectopic levels of the transcription factor E2F-1 on endogenous cdk3-associated kinase activity were also investigated in Rat1 ®broblasts. High levels of ectopic E2F-1 expression was induced in Rat1-p1093E2F-1 cells by treatment with ZnCl 2 . In these cellular systems it has earlier been shown that E2F-1 can induce cdk2-associated kinase activity (Soucek et al., 1997a; Figure 2b) . Under the conditions of these experiments endogenous cdk3-associated kinase activity remained unaected (Figure 2c ). These data prove again that Y20-immunoprecipitates contain a cdk3-associated kinase activity, distinct from cdk2. Our observation that E2F-1 triggers upregulation of cyclin E and cyclin A protein expression and their associated kinase activities but not of cdk3 kinase (Figure 2c and Soucek et al., 1997a) in the same cells suggest that Figure 2 Cdk3-associated kinase activity is independent of 16 and not upregulated upon overexpression of E2F-1, but downregulated by p27. (a) CEM cells (p16-negative acute lymphoblastic leukemia cell line) were transiently transfected with empty control plasmid or with p16 cDNA expressed under the control of the SV-40 promoter (marked +p16). After 2 days of transient expression cells were analysed for p16 protein expression and cdk4-and cdk3-associated kinase activities against pRb. (b) Rat1 cells were transiently transfected with empty control plasmid or with p27 expressed under the control of the CMV promoter (marked +p27). Cell extracts were analysed for Cdk3 activity. (c) Expression of human E2F-1 was induced in Rat1 cells stably transfected with human E2F-1 downstream of a mutated methallothioneine promoter by treatment with 100 mM ZnCl 2 . The expression of human E2F-1 protein was con®rmed by Western blot analysis. Equal amounts of extracts were analysed for kinase activities associated with cdk3, cdk2, cyclin E and cyclin A neither cyclin E nor cyclin A are the regulating partners of cdk3 kinase under these experimental conditions.
Cell cycle regulation of cdk3-associated kinase activity
Logarithmically growing Rat1 cells were sorted by centrifuged elutriation, or synchronized by serum deprivation and restimulation or by serum deprivation and S phase induction upon activation of Myc in Rat1-MycER cells. All approaches clearly revealed that cdk3-associated kinase activity¯uctuates throughout the cell cycle ( Figure 3a ,b and Figure 4c ). Strikingly, although ectopic constitutive overexpression of cdk3 in 4-OHT-activated Rat1-MycER cells was accompanied with an induction of kinase activity in speci®c precipitates, this elevated kinase activity was still cell cycle regulated (Figure 4c ). This ®nding that cdk3-associated kinase activity was regulated independently from its constitutive protein expression was con®rmed by the observation that cdk3 kinase increased whereas cdk3 protein expression was unaected upon serum restimulation ( Figure 3b ). Whereas p21 protein expression remained high, p27 protein decreased during the course of restimulation. The amount of p21 bound to cdk3 remained constant, but p27 disappeared from cdk3 protein when cdk3 kinase became activated during the transition from Go to S phase ( Figure 3b and data not shown).
Comparison of the¯uctuation pattern of cdk3-associated kinase activity and cyclin D1-, E-and Aassociated kinases demonstrated that none of these three cyclin-dependent kinases matched the cdk3 kinase. Cyclin D1 kinase appeared clearly before cdk3 kinase, and cyclin A kinase was induced later than cdk3-associated kinase in the ongoing cell cycle.
The maximum of cyclin E kinase was observed in the S phase fraction, whereas cdk3 kinase peaked mid G1 (Figure 3a) . Further, cdk3-associated kinase activitȳ uctuates during the transition from Go into S phase dierently from the protein expression pattern of cyclin D1, E and A and the¯uctuation of the associated kinases ( Figure 4 ). Taken together, the aforementioned data suggest that the¯uctuation of cdk3 kinase could be regulated by association of cdk3 protein with p27 but is independent on the level of cdk3 protein or the association with p21.
Ectopic cdk3 enhances the process of Myc-induced cell proliferation
Myc has been shown to trigger S phase entry of Go arrested ®broblasts (Eilers et al., 1989; Figure 4) . We wondered whether the elevated cdk3-associated kinase activity in 4-OHT treated Rat1-MycER/cdk3 cells had any eects on the process of Myc-dependent S phase induction. We serum arrested Rat1-MycER control cells (transfected with the empty expression vector) and Rat1-MycER cells stably transfected with cdk3 in medium containing 0.1% serum for 3 days. At dierent time points of Myc activation by 4-OHT cells were ®xed and cyto¯uorometrically analysed for S phase content. Whereas control cells did not initiate replication before 12 h after activation of Myc, cdk3-overexpressing counterparts started to enter S phase already after 4 ± 8 h of Myc activation. At 12 h activation Rat1-MycER/cdk3 cells exhibited about 20% more S phase cells than Rat1-MycER control cells ( Figure 4a ). These experiments were repeated with dierent generated Rat1-MycER cell lines stably transfected with cdk2 or cdk3 and the data were con®rmed by incorporation of radioactive thymidine Figure 3 Cell cycle regulation of cdk3-associated kinase activity. (a) Logarithmically growing Rat1 ®broblasts were separated according to the dierent cell cycle phases by centrifugal elutriation. The obtained cell fractions were cyto¯uorometrically analysed for DNA distribution after staining DNA with propidium iodide (upper panels). Protein extracts of the obtained fractions were analysed for kinase activities associated with cyclin D1 (using pRb as substrate), cdk3, cyclin E and cyclin A (using histone H1). (b) Logarithmically growing Rat1 cells were serum-arrested in medium containing 0.1% serum for 3 days, 0, 4 and 15 h after serum restimulation DNA distributions were analysed on the¯ow cytometer (upper panels). Protein extracts were analysed for cdk3-associated kinase activities, protein levels of cdk3, cdk2, p27 and p21 and for cdk3-associated p27 into DNA (data not shown). Overexpression of cdk2 in Rat1-MycER cells had no eect on the kinetics of Myc-induced S phase entry (data not shown). To rule out possible clonal eects of the generated stable cdk3-overexpressing cell lines we con®rmed this result by analysing Myc-dependent S phase entry in cells transiently transfected with cdk3 ( Figure 5 ). Further investigation revealed that cdk3-dependent enhancement of Myc's capacity to induce proliferation was independent of eects on cyclin D1, E and A and p27 protein expression or cdk2 and cdk4/6 activity ( Figure  4b and c) . Under the conditions of these experiments Extracts of cells, treated as described above, were assayed for cyclin D1, cyclin E, cyclin A and p27 protein expression. (c) Cellular protein extracts of this experiment were analysed for kinase activities associated with cyclin D1 (substrate pRb), cyclin E, cyclin A and cdk3 (substrate H1) Figure 5 Transient transfected cdk3 enhances Myc-induced cell proliferation. Rat1-MycER cells were transiently transfected with empty control vector or with the CMV plasmid containing full length cdk3 cDNA. The cells were cotransfected with CMV-green uorescent protein (GFP) cDNA. After 24 h growth in 0.1% serum Myc was activated by 4-hydroxytamoxifen and S phase content was determined at the indicated time points by selectively analysing GFP-positive cells on the¯ow cytometer Figure 6 Ectopic cdk3 in Myc-overexpressing cells triggers upregulation of E2F-dependent transcription without accompanied induction of protein binding to an E2F consensus site. (a) Rat1-MycER control cells (transfected with the empty vector) and Rat1-MycER cells stably transfected with cdk3 were serum arrested in medium containing 0.1% serum for 3 days. At the indicated time points after activation of Myc by 4-OHT, RNA was prepared, blotted to Nylon ®lters and hybridized with a cDNA probe speci®c for thymidine kinase (TK). Equal amounts of loaded RNA were con®rmed by staining the Northern ®lter with methylene blue. (b) Band shift assays. Protein extracts of the experiment described in (a) were prepared and incubated with a 5' end-labeled DNA fragment corresponding to an E2F binding site from the adenovirus E2 promoter. The speci®city of the resulting protein complexes was investigated by competition with excess of unlabeled probe DNA of either the wild-type or the mutated sequence and data not shown). To visualize the amount of DNA-bound`free' E2F, parallel samples were incubated at 48C in the presence of 0.8% deoxycholate (DOC) for 20 min and then NP-40 was added to a ®nal concentration of 1.5% (c) Rat1-MycER control cells and Rat1-MycER cells stably transfected with cdk3 were transfected with the CAT gene placed under the control of part of the promoter of the murine TK gene either wild-type (WT) or harbouring a mutated E2F binding site (E2F mut). Twenty-four hours later Myc was activated by addition of 4-hydroxytamoxifen (4-OHT), and again 24 h later CAT assays were performed. Radioactivity were counted by an Instant Imager (Packard, Electronic Autoradiograph) and the so obtained data are presented in percentage relative to the highest value (set 100%)
Investigation of the regulation and function of cdk3 K Braun et al we found thymidine kinase (TK) mRNA to be earlier induced in cdk3-overexpressing cells (Figure 6a ). The cell cycle regulation of TK mRNA has earlier been shown to be dependent on the transcription factor family E2F (Nevins, 1992; Ogris et al., 1993; Dou et al., 1994; HengstschlaÈ ger et al., 1996a) . Accordingly, we analysed the eects of cdk3 on protein binding to an E2F binding site of the adenovirus E2 promoter in activated Rat1-MycER cells. Protein binding to the E2F site was unaected upon overexpression of cdk3 (Figure 6b ). Here it is important to note that the sensivitiy of the performed band shift analysis cannot exclude the possibility that small changes in the amount of dierent E2F family members could be induced by cdk3. To assess the contribution of E2F in the observed TK mRNA induction we transfected Rat1-MycER control cells and Rat1-MycER/cdk3 cells with a reporter construct containing the CAT gene driven by part of the murine TK promoter. In parallel, we transfected a construct identical to the wild-type construct described above except that the E2F binding site of the used TK promoter was mutated. Forty-eight hours after transfection and 24 h after activation of Myc by 4-OHT cell extracts were prepared and CAT assays were performed. The G1/S/G2-M distribution of transfected logarithmically growing Rat1-MycER and Rat1-MycER+cdk3 cells was equal (see also the 24 h point in Figure 4a ). On average we observed a 2.5-fold higher CAT activity level in cdk3-overexpressing cells. This transcriptional stimulation of the TK promoter depended entirely on the intact E2F binding site since under the same conditions the mutated construct was not activated (Figure 6c ). Together, these results suggest that cdk3 activates E2F-dependent transcription without upregulation of the DNA binding capacity of E2F.
Ectopic cdk3 enhances the process of anchorage independent growth associated with Myc activation Transformation of primary rat embryo cells by c-Myc is multistep, requiring the cooperation with an activated ras gene (Land et al., 1983) . c-Myc alone, however, is capable of transforming Rat1 cells, associated with anchorage-independent growth (Small et al., 1987; Stone et al., 1987) . We wanted to determine whether high ectopic levels of cdk3 are able to promote anchorage-independent growth or to enhance the process of anchorage-independent growth associated with activation of Myc. Rat1-MycER control cells (transfected with the empty vector) and Rat1-MycER cells stably transfected with cdk2 or cdk3 were grown in soft agar either in the presence or absence of 4-OHT. Treatment with 4-OHT induced formation of adhesion-independent colonies in Rat1-MycER cells, a process which was unaected by ectopic cdk2 but over threefold enhanced in cdk3-overexpressing cells (Figure 7 ). These data were con®rmed using dierent generated Rat1-MycER cell lines stably transfected with cdk2 or cdk3 (data not shown). Without activation of Myc by 4-OHT neither Rat1-MycER nor Rat1-MycER+cdk2 cells formed signi®cant numbers of adhesion-independent colonies. The numbers of colonies formed in Rat1-MycER cells overexpressing cdk3 in the absence of 4-OHT was in a range, which could not safely be evaluated to be signi®cant (Figure 7) . However, these results demonstrate that cdk3, but not cdk2, can enhance the process Figure 7 Ectopic cdk3 enhances the process of Myc-associated anchorage independence. (a) Soft agar growth assays were performed using Rat1-MycER control cells (transfected with the empty vector) and Rat1-MycER cells stably transfected with either cdk2 or cdk3. 10 5 cells were mixed with 0.8% agar and poured onto a bed of 1.4% agar in culture plates. Both top and bottom agar were prepared in DMEM/10% FCS. Cells were fed with DMEM/10% FCS with and without 4-hydroxytamoxifen (4-OHT). Colonies were scored after 2 weeks. (b) The experiment described in (a) was repeated four times and the obatined data are presented in percentage relative to the highest value (set 100%)
Investigation of the regulation and function of cdk3
K Braun et al of anchorage-independent growth associated with activation of Myc.
Cdk3 has no oncogenic potential
It is well known that genetic instability very often parallels the generation of diverse cell populations, including subpopulations with metastasising ability, within a tumor. Genetic instability can be a source of variability and this has been regarded as a driving force in the generation of variants with increased invasive and metastatic potential (Nowell, 1976) . Genetic instability may be indicated by a variety of cellular features at the chromosomal and at the DNA levels. At the chromosomal level, the incidence of aneuploidy, deletions, homogeneously stained regions, double minute chromosomes, etc., are evidence of the instability of the genome (Sherbet and Lakshmi, 1997). Cytogenetic analysis of the described Rat1-MycER, Rat1-MycER/cdk2 and Rat1-MycER/cdk3 cells revealed that neither cdk2 nor cdk3 induced manifestations of genetic instability visible at the chromosomal levels ( Figure 8 ). The data described above show that cdk3 is a positive G1 regulator, which has kinase activity and enhances progression through G1 into S and Mycdependent colony formation in soft agar. All positive regulators tested so far, such as cyclin D1, cyclin D2, cyclin E, cdk4 or cdc25A (see Haas et al., 1997 and references therein) have oncogenic potential. Accordingly, we investigated whether cdk3 has oncogenic activity and whether cdk3 could enhance the process of Myc-dependent malignant transformation. We chose the same experimental conditions as described for the experiments with cdk4 (Haas et al., 1997) . Primary embryonal rat cells were transfected with combinations of activated Ha-ras and Myc, Ha-ras and cdk3 and Ha-ras, Myc and cdk3. As positive controls we used T antigen (T-Ag) or cyclin E; as negative controls the empty expression vector or a dominant negative mutant of cdk3 (van den Heuvel and Harlow, 1993) were used. Overexpression of the transfected proteins was proven by Western blot analysis (data not shown). These experiments demonstrated that cdk3 has no oncogenic potential. We think that the dierences between the results obtained with Ras+Myc compared to Ras+Myc+cdk3 are very likely due to experimental variation. The fact that cdk3 did not increase the rate of Ras+Myc transformation ®ts to our ®nding that cdk3 alone has no oncogenic potential (Table 1) .
Discussion

Novelty of the analysed cdk3-associated kinase activity
Cdk3 has been reported to be required for the G1-S transition in the mammalian cell cycle (van den Heuvel and Harlow, 1993; Hofman and Livingston, 1996) . Figure 8 Ectopic cdk3 does not induce genetic instability at the chromosomal level, such as e.g. aneuploidy, deletions, homogenously stained regions or double minute chromosomes. Shown are metaphase spreads of Rat1-MycER control cells (transfected with the empty expression vector) and of Rat1-MycER cells stably transfected with either cdk2 or cdk3. The chromosomes were prepared of cells which were passaged for at least 2 months in our laboratory. The metaphases shown here are representative for over 100 metaphases analysed in each cell line Oncogenic activity of cdk 3. Given are the numbers of foci obtained after transfection of REFs with the indicated constructs (10 6 cells per transfection). The modi®ed pLTR vector used for expression has been described previously (Haas et al., 1997) . The data represent four independent experiments. n.d., not determined However, until now endogenous cdk3-associated kinase activity has not been analysed. We have obtained the following pieces of evidence that the here analysed kinase activity is novel and associated with cdk3, and that the anti-cdk3 antibodies Y20 and Ab-1 can speci®cally be used to immunoprecipitate this kinase in the used cells. (1) Ectopic expression of cdk3 or cdk3-HA in Myc cells speci®cally triggers elevated kinase activity in anti-cdk3-or anti-HA-immunoprecipitates, respectively. Wherever analysed, the regulation of kinase activity in cdk3-precipitates was identical to the regulation in anti-HA-precipitates, e.g. throughout the cell cycle. (2) Overexpression of p16 leads to downregulation of cdk4-associated kinase activity but not of cdk3 kinase. (3) Overexpression of E2F-1 triggers upregulation of cdk2 but not of cdk3 activity. (4) Cdk3-associated kinase activity¯uctuates throughout the cell cycle; it is not expressed in Go and early G1, peaks in mid G1 and decreases during G2. This uctuation is distinct from the expression pattern of cyclin D1-, cyclin E-and cyclin A-associated kinases, cdk2 and cdk4/6. These observations have been made analysing endogenous cdk3 as well as ectopically expressed cdk3 kinase in Myc-overexpressing cells.
Regulation of cdk3-associated kinase activity
Our data demonstrate that in the ongoing mammalian cell cycle (analysed by centrifugal elutriation) cdk3-associated kinase activity appears after cyclin D1-dependent kinase and before cyclin A-associated kinase. Cyclin E-associated kinase peaks in S phase, cdk3 kinase has its maximum in mid G1. Experiments analysing the transition from Go into the cell cycle revealed that cdk3 kinase is switched o in arrested cells and appears with cyclin E-dependent kinase activity during restimulation. These ®ndings ®t perfectly to the earlier observation that transfection of a dominant-negative mutant of cdk3 arrests cells in G1 (van den Heuvel and Harlow, 1992) .
How is this¯uctuation of cdk3-associated kinase regulated throughout the cell cycle? We show that protein expression of cdk3 is not involved in the regulation of the¯uctuation of the associated kinase: A constitutively overexpressed cdk3 protein is associated with a cell cycle-dependent kinase activity in activated Rat1-MycER cells and cdk3 kinase but not cdk3 protein increases upon serum restimulation. The easiest explanation would be that the regulating partner of cdk3 is one of these G1-S cyclins. Evidence, which suggest that this is the case, comes from the recent ®ndings using recombinant puri®ed proteins: Cdk3 in complexes with cyclin A or cyclin E is active to phosphorylate pRb in vitro (Connell-Crowley et al., 1997) . However, our data make it unlikely that one of these G1-S cyclins solely controls cdk3 cell cycle regulation in vivo.
(1) We found the cell cyclē uctuation of cdk3 kinase (endogenous as well as ectopically overexpressed) to be distinct from the expression pattern of cyclin D1, cyclin E and cyclin A protein and their associated kinases in Rat1 cells. Here it is important to note that the expression of cyclin D3 is constant throughout the cell cycle in these cells . (2) We also demonstrated that overexpression of E2F-1 induces cyclin E and A protein expression and cyclin E-and A-dependent kinase activities but has no eect on cdk3 kinase in the same cells (this report; Soucek et al., 1997a) . (3) It has earlier been reported that activation of Myc in Rat1-MycER cells causes a deregulation of the expression of the G1 cyclins and their associated kinase activities throughout the cell cycle (Steiner et al., 1995; . We found that cdk-3-associated kinase activity does not lose its cell cycle¯uctuation in Myc overexpressing cells. Anyhow, the data obtained so far do not exclude the possibility that one of these G1 cyclins is at least to some extent involved in the regulation of cdk3, especially considering that the cell cycle¯uctuation of cyclin E-associated kinase and cdk3 activity overlap during parts of the cell cycle ( Figure  3a) . Further investigations are necessary to clarify this issue.
Our data suggest that cdk3 kinase is dependent on regulating partner molecule(s): Ectopically expressed cdk3 in Rat1 cells is not active as a kinase and cdk3 activity is cell cycle dependent although its protein levels is unchanged. Using puri®ed recombinant proteins p21 has earlier been shown to inhibit the activity of cdk3 complexed to cyclin E (Harper et al., 1995) . We obtained results, which make it unlikely that p21 is responsible for the cell cycle¯uctuation of cdk3 kinase in vivo.
(1) p21 protein expression was constant in cells where cdk3 kinase¯uctuates. (2) The association of p21 and cdk3 was constant throughout the cell cycle. We further found cdk3 kinase activity to be independent of the cellular status of p16. Whereas cdk4 kinase was downregulated by transient overexpression of p16, cdk3 kinase activity remained unaected. A plausible candidate for a regulator molecule of cdk3 would be the cdk inhibitor p27. p27 inhibits a wide range of cdks (see introduction) and its expression¯uctuates throughout the cell cycle so that it disappears when cdk3-associated kinase activity is induced (Figure 3b and Figure 4) . Indeed, we found cdk3 activity to be downregulated upon transient p27 expression. Furthermore, the association of cdk3 and p27 is lost when cdk3 kinase activity increased during the Go/S transition, which makes it likely that p27 is involved in the regulation of the cell cycle appearance of cdk3 kinase in vivo. Additional support for the role of p27 in regulating cdk3 kinase activity comes from our ®nding that ectopic cdk3 is an active kinase in Myc-overexpressing cells, but not in Rat1 cells. It has earlier been shown that Myc aects the cdk-inhibitory properties of p27 (see Steiner et al., 1995; Vlach et al., 1996; Pusch et al., 1997a; MuÈ ller et al., 1997; Berns et al., 1997) . However, our observation that ectopic cdk3 protein in Myc cells is associated with a kinase activity exhibiting its normal cell cycle regulation also shows that there exists an additional control beside p27.
Function of cdk3
Since we found ectopic cdk3 to be inactive as a kinase in Rat1 cells but to be associated with elevated kinase activity in Myc-overexpressing Rat1 cells, we decided to analyse the consequences of cdk3 expression in the latter cells. We found that high levels of cdk3, but not of cdk2, enhance the process of Myc-induced cell proliferation and of anchorage independent growth associated with Myc activation. Keeping with earlier biological results (van den Heuvel, 1993; Hofmann and Livingston, 1996) this is again evidence that cdk2 and cdk3 operate on dierent molecular targets. This is further suggested by our ®nding that the cell cycle regulation of these two kinase activities is dierent (see above). From our data the question whether overexpression of cdk3 in Rat1-MycER cells without activated Myc can induce anchorage independent growth must remain elusive. The obtained results were in a range at the border between signi®cance and background. The data described above show that cdk3 is a positive G1 regulator, which has kinase activity and enhances progression through G1 into S and Myc-dependent colony formation in soft agar. All positive regulators tested so far, such as cyclin D1, cyclin D2, cyclin E, cdk4 or cdc25A have oncogenic potential (see Haas et al., 1997 and references therein) . However, we found that cdk3 has no oncogenic potential and does not enhance the malignant transformation process induced by high levels of Myc, both analysed in cooperation with an activated ras gene. This ®nding is of particular interest since it has earlier been reported that the gene for cdk3 maps to chromosome 17q22-qter, a locus which was shown to be frequently rearranged in breast cancer and other tumors (Bullrich et al, 1995) . Furthermore, this result once again shows functional dierences between cdk3 and other G1 regulators.
What is the mechanism how ectopic cdk3 mediates its additive eects on Myc function? Considering the data discussed above, one could speculate that overexpression of cdk3`cooperates' with Myc by sequestration of the cdk inhibitor p27. However, we provide evidence against a model in which high levels of cdk3 sequester p27 from other G1 cdks: (1) Overexpression of cdk3 does not induce endogenous cdk2 kinase activity (Figure 1b) . (2) Sequential immunoprecipitation with anti-cdk2 antibody and Western blot analysis with p27 using extracts of Rat1-MycER and Rat1-MycER+cdk3 cells revealed that the amount of p27 bound to endogenous cdk2 does not signi®cantly decrease upon overexpression of cdk3 (Figure 1c) . (3) We found that ectopic cdk3 in Myc-overexpressing cells does neither alter the cell cycle regulation of cyclin D1, cyclin E, cyclin A and p27 protein expression nor that of the kinase activities associated with endogenous cyclin D1, cyclin E and cyclin A (Figure 4) . (4) We further show that the eects of cdk3 in Myc cells, such as enhancement of induction of proliferation or cell adhesion-independent growth, are most likely not due to`super' activation of cdk2: overexpression of cdk2 in Myc cells leads to induction of cdk2 kinase but has no enhancing eects on Myc functions. However, under the conditions of these experiments ectopic cdk3 upand deregulated E2F-dependent transcription very likely independently from upregulation of E2F's DNA binding capacity. These ®ndings are in perfect agreement with the earlier observation that a dominant-negative mutant of cdk3 inhibits E2F-1-3 but not E2F-4 transcription activity in a pRbindependent manner. This inhibition was not a result of failure of E2F-1 to bind to DNA or to heterodimerize with its DP partner (Hofmann and Livingston, 1996) . Hofmann and Livingston suggest a model how cdk3 could participate in the process of S phase entry: It was proposed that cdk2 is active in phosphorylating pRb and releasing E2F, beside other functions necessary for S phase entry. Cdk3 also contributes to the activation of E2F, beside possible other functions, thereby licensing events necessary for S phase entry. Since cdk3-mediated eects on E2F-dependent transcription are independent of alterations of E2F's DNA binding capacity (Hofmann and Livingston, 1996 and our data), it seems likely that cdk3 function is required for the activation of E2F as a transcription modulating element, perhaps by allowing speci®c, functional cross-talk between E2F and either the basal transcription machinery or a putative coactivator required for E2F transcriptional activity. All our data on regulation and function of cdk3 not only ®t into but strongly support this model. Whether cdk3 acts before or after the release of E2F from pRb induced by phosphorylation remained elusive from the experiments performed by Hofmann and Livingston. Our observation that cdk3 kinase activity appears later than cdk4/6 kinase throughout the cell cycle argues that cdk3 very likely acts after release of E2F from pRb.
Materials and methods
Cells and tissue culture
Establishment and cultivation of the Rat-1 cell lines used in this study have been described previously (Eilers et al., 1989; Littlewood et al., 1995) . Myc functions were activated with 100 nM 4-hydroxytamoxifen (4-OHT). Rat1 cells constitutively expressing cdk2 or cdk3 were created by the following procedure: Puromycin-resistant Rat1-pBpuro (empty vector) and Rat1-MycER cells were transfected with a G418-resistant CMV expression plasmid (to obtain control cells), the CMV plasmid containing full length human cdk2 cDNA, the CMV plasmid containing full length human cdk3 DNA, or hemagglutinin (HA)-tagged cdk2 or cdk3 (van den Heuvel and Harlow, 1993) by calcium phosphate precipitation. After selection, puromycin/G418 doubly resistant clones (about 120) were pooled to generate dierent cell lines. The whole procedure was repeated to obtain dierent cell lines of each combination. All rodent cell lines (Rat1, 3T3) were grown in Dulbecco's modi®ed Eagle's medium (DMEM), the human cell lines (CEM, APL) were grown in RPMI-1640 medium both supplemented with 10% calf serum and antibiotics (30 mg/ liter penicillin, 50 mg/liter streptomycin sulfate). For detailed description of the dierent human cell lines see HengstschlaÈ ger et al. (1996b) and Soucek et al. (1997b) . All cultures were kept at 378C and 7% CO 2 , and routinely screened for mycoplasma.
Flow cytometry, 3 H-thymidine incorporation and centrifugal elutriation
For cyto¯uorometric analyses cells were harvested by trypsinization and ®xed by rapid submersion in 5 ml of ice-cold 85% ethanol. After at least 1 h ®xation at 7208C cells were pelleted and stained in 1 ml staining solution (0.25 mg/ml propidium iodide, 0.05 mg/ml RNAse, 0.1% Triton X-100 in citrat buer (pH 7.8)). Stained cells were analysed on a Becton-Dickinson FACScan. In addition, growth rates were determined by pulse labeling with radiolabeled thymidine. Labeled DNA was precipitated by trichloracetic acid collected on glass ®ber ®lters and quantitated by scintillation counting . Separation of logarithmically growing cells into distinct cell cycle phases was accomplished by centrifugal elutriation in a Beckman J2-21 M centrifuge and a JE-6B rotor with a standard separation chamber. The rotor was kept at a speed of 2000 r.p.m., temperature was 208C, and medium ow was controlled with a Cole-Parmer Master¯ex pump. Consecutive fractions of 150 ± 300 ml were collected at increasing¯ow rates . Cytofluorometric analyses of cell cycle distributions were performed as described above.
Western blot and Northern blot analyses
Protein extracts were prepared in buer containing 20 mM HEPES pH 7.9, 0.4 M NaCl, 2.5% glycerol, 1 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 0.02 mg/ml leupeptin, 0.02 mg/ml aprotinin, 0.003 mg/ml benzamidinchloride, 0.1 mg/ml trypsin inhibitor, and 0.5 mM DTT. After 20 min on ice, the extracts were centrifuged and supernatants were stored at 7708C. Western blot analyses were performed as described . The following antibodies were used: against p16, p16 (Pharmingen); p21, p21 (sc-397, St. Cruz); p27, C19 (sc-528, St. Cruz); cdk2, M2 (sc-163/sc-163G, St. Cruz); cdk3, Y20 (sc-826, St. Cruz); cdk3, Ab-1 (RB-015PO, Neomarkers); Ha-tag, 12CA5 (Boehringer Mannheim); E2F-1, KH95 (Pharmingen); cyclin E, M20 (sc-481, St. Cruz); cyclin A, H432 (sc-751, St. Cruz); cyclin D1 (DCS-6, Progen).
The used protocol for RNA extraction and Northern blot analysis was described earlier and hybridization probe was full length mouse thymidine kinase cDNA (HengstchlaÈ ger et al., 1996a).
Immunoprecipitations and immune complex kinase assays
Protein extracts were prepared as described above. Cyclin immunoprecipitations and analyses of cyclin-dependent kinases were performed according to (Dulic et al., 1992) . The following antibodies were used: against cdk2, M2 (sc-163/sc-163G, St. Cruz); cdk3, Y20 (sc-826, St. Cruz); cdk3, Ab-1 (RB-015PO, Neomarkers); Ha-tag, 12CA5 (Boehringer Mannheim); cdk4, C22 (sc-260, St. Cruz); cyclin E, M20 (sc-481, St. Cruz); cyclin A, H432 (sc-751, St. Cruz); cyclin D1 (DCS-11, Neomarkers); substrates were histone H1 and GST-pRb .
Band shift analyses
Protein was extracted as described above. Gel mobility shift analyses were carried out with 5 ± 10 mg extract as described; synthetic oligonucleotides corresponding to both strands of the wild-type or mutant distal E2F binding site of the adenovirus E2 promoter were used (Pusch et al., 1997a,b) . Deoxycholate treatment was performed as described (Bagchi et al., 1990) .
Transient transfections and CAT assays
Plasmids used for transfection contained p16 cDNA cloned downstream of the constitutive late promoter of Simian Virus 40 (HengstschlaÈ ger et al, 1996a) , p27 cDNA in the CMV-expression vector pcDNA3, cdk3 cDNA in CMV plasmid, green¯uorescent protein (GFP) cDNA in pEGFP-C1 (CMV promoter), or were constructed using parts of the genomic clones of mouse thymidine kinase (TK) promoter and a commercially available chloramphenicol acetyltransferase (CAT) plasmid (Ogris et al., 1993) . In the latter mutations in the E2F sites were introduced by using oligonucleotides carrying the mutations and the in vitro mutagenesis system of Amersham as recommended by the supplier. For transfections of plasmids, cells were treated with 15 mg DNA, using the calcium-phosphate method as described earlier (HengstschlaÈ ger et al., 1996a) . Forty-eight hours after transfection CAT assays were performed according to Gorman (1985) .
Chromosome preparations, soft agar growth assays and rat embryo ®broblast transformation assays
Chromosomes were prepared and stained as described (HengstschlaÈ ger et al., 1996b) . For the soft agar growth assays, 10 5 cells were mixed with 0.8% agar and poured onto a bed of 1.4% agar in culture plates. Both top and bottom agar were prepared in DMEM/10% FCS. Cells were fed every week with 2 ml of DMEM/10% FCS. For the rat embryo ®broblast transformation assays pregnant Fisher rats were killed at day 14, the embryos were removed and placed in sterile PBS. Cells from the carcass were dispersed using trypsin/EDTA/1% chicken serum. The cells were separated from the debris by low speed centrifugation. The cells were resuspended in DMEM/10% FCS and plated at 1 million cells per a 80 cm 2 dish. After cells had reached con¯uency, they were replated at a density of 1 million per dish and used for transfections the following day. Transfections were carried out by the calcium phosphate method overnight with 30 mg of DNA per dish. Sixteen hours after transfection the cells were washed with PBS and fed with fresh medium and another 24 h later were split into four plates and assayed for focus formation (Haas et al., 1997) .
